| pubmed-article:15541473 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0026986 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0302600 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:15541473 | lifeskim:mentions | umls-concept:C0051844 | lld:lifeskim |
| pubmed-article:15541473 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15541473 | pubmed:dateCreated | 2004-11-15 | lld:pubmed |
| pubmed-article:15541473 | pubmed:abstractText | Angiogenesis is implicated in the progression of myelodysplastic syndromes (MDS). Bone marrow microvascular density (MVD), serum angiogenin (ANG) and interleukin 6 (IL-6) were measured in 67 patients with untreated MDS. MVD, ANG and IL-6 were significantly higher in the patient group as a whole when compared to controls (P < 0.01). MVD and ANG were significantly higher in subtypes with a high-risk for leukemic transformation (RAEB, RAEB-t and CMML) than in low-risk subtypes (RA and RARS) (P < 0.01). In the MDS group, a positive correlation was found between ANG and IL-6 (P < 0.001) and also between MVD and IL-6 (P < 0.05). Using multivariate analysis, only IL-6 displayed independent prognostic value and was inversely related to MDS survival. | lld:pubmed |
| pubmed-article:15541473 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15541473 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15541473 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15541473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15541473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15541473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15541473 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15541473 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15541473 | pubmed:issn | 0145-2126 | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:DamilakisJohn... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:AlexandrakisM... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:StathopoulosE... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:PassamFreda... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:KyriakouDespi... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:PappaConstant... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:SfiridakiKate... | lld:pubmed |
| pubmed-article:15541473 | pubmed:author | pubmed-author:TsirakisGeorg... | lld:pubmed |
| pubmed-article:15541473 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15541473 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:15541473 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15541473 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15541473 | pubmed:pagination | 41-6 | lld:pubmed |
| pubmed-article:15541473 | pubmed:dateRevised | 2011-7-19 | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:meshHeading | pubmed-meshheading:15541473... | lld:pubmed |
| pubmed-article:15541473 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15541473 | pubmed:articleTitle | Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes. | lld:pubmed |
| pubmed-article:15541473 | pubmed:affiliation | Department of Haematology, University Hospital of Heraklion, Medical School of Crete, P.O. Box 1352, Heraklion, Crete, Greece. freda@med.uoc.gr | lld:pubmed |
| pubmed-article:15541473 | pubmed:publicationType | Journal Article | lld:pubmed |
